These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 18289857)
21. Analgesic Effects of 5-Alkyloxy-4-amino-2(5H)-furanones as Cholecystokinin-2 Antagonists. Lattmann E; Sattayasai J; Schwalbe CH; Boonprakob Y; Dunn S; Fajana F; Lattmann P Arch Pharm (Weinheim); 2016 Jun; 349(6):456-65. PubMed ID: 27142294 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological analysis of CCK2 receptors up-regulated using engineered transcription factors. Morton MF; Liu PQ; Reik A; de la Rosa R; Mendel M; Li XY; Case C; Pabo C; Moreno V; Pyati J; Shankley NP Regul Pept; 2005 Jul; 129(1-3):227-32. PubMed ID: 15927720 [TBL] [Abstract][Full Text] [Related]
23. Combinatorial solid phase synthesis of multiply substituted 1,4-benzodiazepines and affinity studies on the CCK2 receptor (part 1). Lattmann E; Billington DC; Poyner DR; Arayarat P; Howitt SB; Lawrence S; Offel M Drug Des Discov; 2002; 18(1):9-21. PubMed ID: 12375632 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of 2,3,5,6-tetrahydro-3H-imidazo[2,1-b] [1,3,5]benzotriazepines and their oxidative ring contraction into 1-(4,5-dihydro-1H-imidazol-2-yl)-1H-benzimidazoles. Saczewski F; Kobierska E; Tyacke RJ; Hudson AL; Nutt DJ; Gdaniec M Farmaco; 2005 Feb; 60(2):127-34. PubMed ID: 15752471 [TBL] [Abstract][Full Text] [Related]
25. 8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists. Gilligan PJ; He L; Clarke T; Tivitmahaisoon P; Lelas S; Li YW; Heman K; Fitzgerald L; Miller K; Zhang G; Marshall A; Krause C; McElroy J; Ward K; Shen H; Wong H; Grossman S; Nemeth G; Zaczek R; Arneric SP; Hartig P; Robertson DW; Trainor G J Med Chem; 2009 May; 52(9):3073-83. PubMed ID: 19361210 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of aryl-1,2,4-triazine-3,5-diones as antagonists of the gonadotropin-releasing hormone receptor. Pontillo J; Guo Z; Wu D; Struthers RS; Chen C Bioorg Med Chem Lett; 2005 Oct; 15(19):4363-6. PubMed ID: 16046130 [TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists. Guo Z; Wu D; Zhu YF; Tucci FC; Regan CF; Rowbottom MW; Struthers RS; Xie Q; Reijmers S; Sullivan SK; Sai Y; Chen C Bioorg Med Chem Lett; 2005 Aug; 15(16):3685-90. PubMed ID: 15951171 [TBL] [Abstract][Full Text] [Related]
28. 2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists. Carling RW; Russell MG; Moore KW; Mitchinson A; Guiblin A; Smith A; Wafford KA; Marshall G; Atack JR; Street LJ Bioorg Med Chem Lett; 2006 Jul; 16(13):3550-4. PubMed ID: 16621541 [TBL] [Abstract][Full Text] [Related]
29. Design and discovery of 1,3-benzodiazepines as novel dopamine antagonists. Zhu Z; Sun ZY; Ye Y; McKittrick B; Greenlee W; Czarniecki M; Fawzi A; Zhang H; Lachowicz JE Bioorg Med Chem Lett; 2009 Sep; 19(17):5218-21. PubMed ID: 19643610 [TBL] [Abstract][Full Text] [Related]
30. How a single inversion of configuration leads to a reversal of the binding mode: proposal of a novel arrangement of CCK2 ligands in their receptor, and contribution to the development of peptidomimetic or non-peptide CCK2 ligands. Bellier B; Garbay C Eur J Med Chem; 2003; 38(7-8):671-86. PubMed ID: 12932898 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists. Tsukamoto I; Koshio H; Kuramochi T; Saitoh C; Yanai-Inamura H; Kitada-Nozawa C; Yamamoto E; Yatsu T; Shimada Y; Sakamoto S; Tsukamoto S Bioorg Med Chem; 2009 Apr; 17(8):3130-41. PubMed ID: 19321349 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of novel benzimidazole derivative [Bz-Im] and its radio/biological studies. Tiwari AK; Mishra AK; Bajpai A; Mishra P; Singh S; Sinha D; Singh VK Bioorg Med Chem Lett; 2007 May; 17(10):2749-55. PubMed ID: 17368898 [TBL] [Abstract][Full Text] [Related]
34. The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists. Lunniss GE; Barnes AA; Barton N; Biagetti M; Bianchi F; Blowers SM; Caberlotto L; Emmons A; Holmes IP; Montanari D; Norris R; Walters DJ; Watson SP Bioorg Med Chem Lett; 2009 Aug; 19(15):4022-5. PubMed ID: 19581086 [TBL] [Abstract][Full Text] [Related]
35. Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation. Ralbovsky JL; Lisko JG; Palmer JM; Mabus J; Chevalier KM; Schulz MJ; Dyatkin AB; Miskowski TA; Coats SJ; Hornby P; He W Bioorg Med Chem Lett; 2009 May; 19(10):2661-3. PubMed ID: 19375913 [TBL] [Abstract][Full Text] [Related]
36. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity. Zhang J; Zhang H; Cai W; Yu L; Zhen X; Zhang A Bioorg Med Chem; 2009 Jul; 17(14):4873-80. PubMed ID: 19559623 [TBL] [Abstract][Full Text] [Related]
37. Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives as novel small molecule chaperone amplifiers. Zhou Y; Wei L; Brady TP; Murali Mohan Redddy PS; Nguyen T; Chen J; Au Q; Yoon IS; Yip G; Zhang B; Barber JR; Ng SC Bioorg Med Chem Lett; 2009 Aug; 19(15):4303-7. PubMed ID: 19502057 [TBL] [Abstract][Full Text] [Related]
38. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems. Micheli F; Bonanomi G; Braggio S; Capelli AM; Damiani F; Di Fabio R; Donati D; Gentile G; Hamprecht D; Perini O; Petrone M; Tedesco G; Terreni S; Worby A; Heidbreder C Bioorg Med Chem Lett; 2008 Feb; 18(3):908-12. PubMed ID: 18178090 [TBL] [Abstract][Full Text] [Related]
39. 7-Sulfonamido-3-benzazepines as potent and selective 5-HT2C receptor agonists: hit-to-lead optimization. Fish PV; Brown AD; Evrard E; Roberts LR Bioorg Med Chem Lett; 2009 Apr; 19(7):1871-5. PubMed ID: 19269173 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists. Gilligan PJ; Clarke T; He L; Lelas S; Li YW; Heman K; Fitzgerald L; Miller K; Zhang G; Marshall A; Krause C; McElroy JF; Ward K; Zeller K; Wong H; Bai S; Saye J; Grossman S; Zaczek R; Arneric SP; Hartig P; Robertson D; Trainor G J Med Chem; 2009 May; 52(9):3084-92. PubMed ID: 19361209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]